{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:33:51Z","timestamp":1788813231153,"version":"build-2803163510"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Innate immune system activation and inflammation are associated with and may contribute to clinical outcomes in people with Down syndrome (DS), neurodegenerative diseases such as Alzheimer\u2019s disease (AD), and normal aging. In addition to serving as potential diagnostic biomarkers, innate immune system activation and inflammation may play a contributing or causal role in these conditions, leading to the hypothesis that effective therapies should seek to dampen their effects. However, recent intervention studies with the innate immune system activator granulocyte-macrophage colony-stimulating factor (GM-CSF) in animal models of DS, AD, and normal aging, and in an AD clinical trial suggest that activating the innate immune system and inflammation may instead be therapeutic. We consider evidence that DS, AD, and normal aging are accompanied by innate immune system activation and inflammation and discuss whether and when during the disease process it may be therapeutically beneficial to suppress or promote such activation.<\/jats:p>","DOI":"10.3389\/fnagi.2021.718426","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T01:21:30Z","timestamp":1631755290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?"],"prefix":"10.3389","volume":"13","author":[{"given":"Md. Mahiuddin","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J.","family":"Chial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huntington","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/cells9092132","article-title":"Microglia and macrophages in the pathological central and peripheral nervous systems","volume":"9","author":"Abe","year":"2020","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-x","article-title":"Immunochemical identification of the serine protease inhibitor \u03b1 1-antichymotrypsin in the brain amyloid deposits of Alzheimer\u2019s disease","volume":"52","author":"Abraham","year":"1988","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"216.e1","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial and its follow-up study","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/hmg\/ddt017","article-title":"Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain","volume":"22","author":"Ahmed","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1021\/pr2011582","article-title":"Loss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome","volume":"11","author":"Ahmed","year":"2012","journal-title":"J. Proteome Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.04.451073","article-title":"Pro-inflammatory cytokine GM-CSF improves learning\/memory and brain pathology in Dp16 down syndrome mice and improves learning\/memory in wild-type mice","author":"Ahmed","year":"2021","journal-title":"bioRxiv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0197-4580(00)00124-x","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B8","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnride","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psychiatr. Psych. Gerichtl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"577272","DOI":"10.1016\/j.jneuroim.2020.577272","article-title":"The association between systemic inflammation and cognitive performance in healthy adults","volume":"345","author":"Ashraf-Ganjouei","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1182\/blood.v82.11.3279.bloodjournal82113279","article-title":"Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes","volume":"82","author":"Baldwin","year":"1993","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2018.10.009","article-title":"Distinct cytokine profiles in human brains resilient to Alzheimer\u2019s pathology","volume":"121","author":"Barroeta-Espar","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","article-title":"Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias","volume":"10","author":"Beecham","year":"2014","journal-title":"PLoS Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-170602","article-title":"Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer\u2019s disease pathology and neuronal damage","volume":"62","author":"Bettcher","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2021.02.012","article-title":"Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer\u2019s disease","volume":"103","author":"Bettcher","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1567205043332243","article-title":"Cystathionine \u03b2 synthase as a risk factor for Alzheimer disease","volume":"1","author":"Beyer","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a pro-inflammatory and a regulatory cytokine: implications for immune therapy","volume":"35","author":"Bhattacharya","year":"","journal-title":"J. Interferon Cytokine Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","article-title":"GM-CSF: an immune modulatory cytokine that can suppress autoimmunity","volume":"75","author":"Bhattacharya","year":"","journal-title":"Cytokine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"Bittles","year":"2007","journal-title":"Eur. J. Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13293-015-0043-9","article-title":"Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome","volume":"6","author":"Block","year":"2015","journal-title":"Biol. Sex Differ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/ijms20040834","article-title":"Innate immune modulation by GM-CSF and IL-3 in health and disease","volume":"20","author":"Borriello","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.imlet.2010.08.005","article-title":"Expression of IFN\u03b3R2 mutated in a dileucine internalization motif reinstates IFN\u03b3 signaling and apoptosis in human T lymphocytes","volume":"134","author":"Boselli","year":"2010","journal-title":"Immunol. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2010-091471","article-title":"GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice","volume":"21","author":"Boyd","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","article-title":"Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors","volume":"286","author":"Brodbeck","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","article-title":"Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment","volume":"31","author":"Buchhave","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3233\/JAD-161304","article-title":"Alterations in the peripheral immune system in dementia","volume":"58","author":"Busse","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/bj3060599","article-title":"Fibrillogenesis in Alzheimer\u2019s disease of amyloid \u03b2 peptides and apolipoprotein E","volume":"306","author":"Castano","year":"1995","journal-title":"Biochem. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nature22067","article-title":"Human umbilical cord plasma proteins revitalize hippocampal function in aged mice","volume":"544","author":"Castellano","year":"2017","journal-title":"Nature"},{"key":"B32","first-page":"1301","article-title":"Improved national prevalence estimates for 18 selected major birth defects\u2014United States, 1999\u20132001","volume":"54","year":"2006","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1096\/fj.10-175976","article-title":"High ability of apolipoprotein E4 to stabilize amyloid-\u03b2 peptide oligomers, the pathological entities responsible for Alzheimer\u2019s disease","volume":"25","author":"Cerf","year":"2011","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P","article-title":"Behavioral phenotype of individuals with Down syndrome","volume":"6","author":"Chapman","year":"2000","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/187152710791012053","article-title":"Assessing activation states in microglia","volume":"9","author":"Colton","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the early detection and progression of Alzheimer\u2019s disease","volume":"14","author":"Counts","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1742-2094-9-179","article-title":"Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study","volume":"9","author":"Cribbs","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/glia.22732","article-title":"APOE genotype-dependent modulation of astrocyte chemokine CCL3 production","volume":"63","author":"Cudaback","year":"2015","journal-title":"Glia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1073\/pnas.83.11.3619","article-title":"Human Cu\/Zn superoxide dismutase gene family: molecular structure and characterization of four Cu\/Zn superoxide dismutase-related pseudogenes","volume":"83","author":"Danciger","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1192\/bjp.176.5.468","article-title":"APOE epsilon 4 influences the manifestation of Alzheimer\u2019s disease in adults with Down\u2019s syndrome","volume":"176","author":"Deb","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3233\/JAD-2010-100921","article-title":"Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"22","author":"Diniz","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat. Med."},{"key":"B46","first-page":"31","article-title":"The consequences of chromosome imbalance","volume":"7","author":"Epstein","year":"1990","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","article-title":"Evolution of neuroinflammation across the lifespan of individuals with Down syndrome","volume":"143","author":"Flores-Aguilar","year":"2020","journal-title":"Brain"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10522-015-9578-8","article-title":"Inflammaging decreases adaptive and innate immune responses in mice and humans","volume":"17","author":"Frasca","year":"2016","journal-title":"Biogerontology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","article-title":"Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"27","author":"Galimberti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1128\/MCB.26.10.3864-3874.2006","article-title":"Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis","volume":"26","author":"Ganesh","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/DDDT.S51476","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations","volume":"9","author":"Gardiner","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291x(84)91209-9","article-title":"Alzheimer\u2019s disease and Down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1074\/jbc.271.18.10602","article-title":"The interaction between apolipoprotein E and Alzheimer\u2019s amyloid \u03b2-peptide is dependent on \u03b2-peptide conformation","volume":"271","author":"Golabek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fnmol.2019.00125","article-title":"MicroRNAs in microglia: how do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma?","volume":"12","author":"Guo","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1212\/01.wnl.0000255938.33739.46","article-title":"Variations in the APP gene promoter region and risk of Alzheimer disease","volume":"68","author":"Guyant-Mar\u00e9chal","year":"2007","journal-title":"Neurology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in down syndrome and the development of Alzheimer\u2019s disease neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/jcm10091907","article-title":"Cross-sectional exploration of plasma biomarkers of Alzheimer\u2019s disease in down syndrome: early data from the longitudinal investigation for enhancing down syndrome research (LIFE-DSR) study","volume":"10","author":"Hendrix","year":"2021","journal-title":"J. Clin. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fped.2020.00073","article-title":"Immune dysregulation in children with down syndrome","volume":"8","author":"Huggard","year":"","journal-title":"Front. Pediatr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"154938","DOI":"10.1016\/j.cyto.2019.154938","article-title":"Increased systemic inflammation in children with Down syndrome","volume":"127","author":"Huggard","year":"","journal-title":"Cytokine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"P1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ejhg.2008.122","article-title":"Twenty-year trends in prevalence and survival of Down syndrome","volume":"16","author":"Irving","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u2019s disease and Creutzfeldt-Jakob disease","volume":"17","author":"Jesse","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1000101","DOI":"10.4172\/bdt.1000101","article-title":"Granulocyte macrophage colony stimulating factor treatment is associated with improved cognition in cancer patients","volume":"1","author":"Jim","year":"2012","journal-title":"Brain Disord. Ther."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.28.437389","article-title":"Imipramine and olanzapine block apoE4-catalyzed polymerization of A\u03b2 and show evidence of improving Alzheimer\u2019s disease cognition","author":"Johnson","year":"","journal-title":"bioRxiv"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.20.436288","article-title":"Sex-specific life extension in tauopathy mice by CSF1R inhibition causing selective microglial depletion and suppressed pathogenesis","author":"Johnson","year":"","journal-title":"bioRxiv"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20180653","article-title":"Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau","volume":"215","author":"Kang","year":"2018","journal-title":"J. Exp. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1004758","DOI":"10.1371\/journal.pgen.1004758","article-title":"Genome-wide association study of CSF levels of 59 alzheimer\u2019s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation","volume":"10","author":"Kauwe","year":"2014","journal-title":"PLoS Genet."},{"key":"B71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2014.11.002","article-title":"Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma","volume":"278","author":"Kelso","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1276.e7","DOI":"10.1016\/j.jneuroim.2014.11.002","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0378-1119(97)00240-0","article-title":"Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2","volume":"196","author":"Kim","year":"1997","journal-title":"Gene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","article-title":"Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"436","author":"Kim","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","article-title":"Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer\u2019s disease mice","volume":"319","author":"Kiyota","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-\u03b2","volume":"135","author":"Koffie","year":"2012","journal-title":"Brain"},{"key":"B78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3171\/2008.12.JNS08172","article-title":"Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation","volume":"111","author":"Kong","year":"2009","journal-title":"J. Neurosurg."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"P566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1074\/jbc.M700356200","article-title":"Regulated intramembrane proteolysis of the interleukin-1 receptor II by \u03b1-, \u03b2-, and \u03b3-secretase","volume":"282","author":"Kuhn","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1074\/jbc.272.1.556","article-title":"Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene","volume":"272","author":"Kuno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1007\/s12035-020-02106-x","article-title":"Altered expression of long non-coding RNAs in peripheral blood mononuclear cells of patients with Alzheimer\u2019s disease","volume":"57","author":"Kurt","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.mp.4001974","article-title":"Evidence for the association of the S100\u03b2 gene with low cognitive performance and dementia in the elderly","volume":"12","author":"Lambert","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"B87","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s12035-018-1113-x","article-title":"LPS-induced inflammation abolishes the effect of DYRK1A on IkB stability in the brain of mice","volume":"56","author":"Latour","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bbrc.2012.03.007","article-title":"The transcription factor STAT2 enhances proteasomal degradation of RCAN1 through the ubiquitin E3 ligase FBW7","volume":"420","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jnr.23205","article-title":"Granulocyte macrophage colony-stimulating factor promotes regeneration of retinal ganglion cells in vitro through a mammalian target of rapamycin-dependent mechanism","volume":"91","author":"Legacy","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1871527315666160202125914","article-title":"Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system","volume":"15","author":"Leszek","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1046\/j.1471-4159.1998.71041421.x","article-title":"S100 \u03b2 increases levels of \u03b2-amyloid precursor protein and its encoding mRNA in rat neuronal cultures","volume":"71","author":"Li","year":"1998","journal-title":"J. Neurochem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","article-title":"Anti-ApoE antibody given after plaque onset decreases A\u03b2 accumulation and improves brain function in a mouse model of A\u03b2 amyloidosis","volume":"34","author":"Liao","year":"2014","journal-title":"J. Neurosci."},{"key":"B93","first-page":"79","article-title":"Two polymorphisms of RCAN1 gene associated with Alzheimer\u2019s disease in the Chinese Han population","volume":"21","author":"Lin","year":"2011","journal-title":"East Asian Arch. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"P1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"B96","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1471-4159.2004.02909.x","article-title":"S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors","volume":"92","author":"Liu","year":"2005","journal-title":"J. Neurochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"P1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"B97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2012.9","article-title":"Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"Lucin","year":"2009","journal-title":"Neuron"},{"key":"B100","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neurobiolaging.2006.10.001","article-title":"Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer\u2019s disease","volume":"29","author":"Lv","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B101","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0197-4580(96)00112-1","article-title":"Alzheimer A \u03b2 neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A \u03b2-related peptides","volume":"17","author":"Ma","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"B102","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins \u03b1 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer \u03b2-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-2094-3-10","article-title":"Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice","volume":"3","author":"Maezawa","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"B104","doi-asserted-by":"publisher","first-page":"31736","DOI":"10.1074\/jbc.M114.609396","article-title":"A role for stefin B (cystatin B) in inflammation and endotoxemia","volume":"289","author":"Maher","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.neurobiolaging.2006.05.024","article-title":"A\u03b242 neurotoxicity in primary co-cultures: effect of apoE isoform and A\u03b2 conformation","volume":"28","author":"Manelli","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B107","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/jad-2006-9s330","article-title":"Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years","volume":"9","author":"McGeer","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/wnl.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s0006-8993(96)01324-8","article-title":"Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates \u03b2-amyloid protein activation of complement in vitro","volume":"749","author":"McGeer","year":"1997","journal-title":"Brain Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/brain\/120.11.2083","article-title":"Granulocyte-macrophage colony-stimulating factor crosses the blood\u2014brain and blood\u2014spinal cord barriers","volume":"120","author":"McLay","year":"1997","journal-title":"Brain"},{"key":"B111","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer\u2019s disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B112","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"B113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2005.04.008","article-title":"Chromosome 21 BACE2 haplotype associates with Alzheimer\u2019s disease: a two-stage study","volume":"236","author":"Myllykangas","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21037\/atm.2019.10.66","article-title":"Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders","volume":"7","author":"Niu","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ajmg.b.30485","article-title":"Association studies testing for risk for late-onset Alzheimer\u2019s disease with common variants in the \u03b2-amyloid precursor protein (APP)","author":"Nowotny","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B116","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-014-0075-0","article-title":"Blocking the apoE\/A\u03b2 interaction ameliorates A\u03b2-related pathology in APOE epsilon2 and epsilon4 targeted replacement Alzheimer model mice","volume":"2","author":"Pankiewicz","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B117","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neulet.2010.10.010","article-title":"Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer\u2019s disease in subjects with Down syndrome","volume":"487","author":"Patel","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B118","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/genes12030419","article-title":"Set-based rare variant expression quantitative trait loci in blood and brain from alzheimer disease study participants","volume":"12","author":"Patel","year":"2021","journal-title":"Genes"},{"key":"B119","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0166-2236(88)90110-5","article-title":"Macrophages and microglia in the nervous system","volume":"11","author":"Perry","year":"1988","journal-title":"Trends Neurosci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/dneu.22714","article-title":"Blood-based biomarkers for Down syndrome and Alzheimer\u2019s disease: a systematic review","volume":"79","author":"Petersen","year":"2019","journal-title":"Dev. Neurobiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"P887","DOI":"10.1016\/j.neuron.2020.09.010","article-title":"Rescuing over-activated microglia restores cognitive performance in juvenile animals of the Dp(16) mouse model of down syndrome","volume":"108","author":"Pinto","year":"2020","journal-title":"Neuron"},{"key":"B122","article-title":"Beyond \u03b2 protein\u2014the essential role of inflammation in Alzheimer amyloid formation","volume-title":"Inflammatory Events in Neurodegeneration","author":"Potter","year":"2001"},{"key":"B123","doi-asserted-by":"publisher","first-page":"489428","DOI":"10.1155\/2012\/489428","article-title":"Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade","volume":"2012","author":"Potter","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e12158","DOI":"10.1002\/trc2.12158","article-title":"Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer\u2019s disease","volume":"7","author":"Potter","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat. Commun."},{"key":"B126","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","article-title":"Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata","volume":"5","author":"Rachubinski","year":"2019","journal-title":"JAAD Case Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B128","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1172\/JCI96209","article-title":"Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology","volume":"128","author":"Rangasamy","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B129","doi-asserted-by":"publisher","first-page":"939786","DOI":"10.1155\/2013\/939786","article-title":"The role of the innate immune system in Alzheimer\u2019s disease and frontotemporal lobar degeneration: an eye on microglia","volume":"2013","author":"Ridolfi","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/jid.2009.223","article-title":"RIP4 regulates epidermal differentiation and cutaneous inflammation","volume":"130","author":"Rountree","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/(sici)1096-8628(19990820)88:4<344::aid-ajmg10>3.0.co;2-1","article-title":"Apo E genotypes and risk of dementia in Down syndrome","volume":"88","author":"Rubinsztein","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"B132","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0002-9440(10)63355-x","article-title":"A synthetic peptide blocking the apolipoprotein E\/\u03b2-amyloid binding mitigates \u03b2-amyloid toxicity and fibril formation in vitro and reduces \u03b2-amyloid plaques in transgenic mice","volume":"165","author":"Sadowski","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI117407","article-title":"Apolipoprotein E associates with \u03b2 amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3","volume":"94","author":"Sanan","year":"1994","journal-title":"J. Clin. Invest."},{"key":"B134","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0304-3940(93)90396-3","article-title":"Expression of cytokine receptors in cultured neuronal and glial cells","volume":"160","author":"Sawada","year":"1993","journal-title":"Neurosci. Lett."},{"key":"B135","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.jcbfm.9600496","article-title":"A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF)","volume":"28","author":"Sch\u00e4bitz","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B136","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00417-012-1932-9","article-title":"GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins","volume":"250","author":"Schallenberg","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study","volume":"52","author":"Schmidt","year":"2002","journal-title":"Ann. Neurol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/01.STR.0000259707.43496.71","article-title":"Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion","volume":"38","author":"Schneider","year":"2007","journal-title":"Stroke"},{"key":"B139","doi-asserted-by":"publisher","first-page":"C155","DOI":"10.1152\/ajpcell.00143.2010","article-title":"Cystathionine \u03b2-synthase and cystathionine \u03b3-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation","volume":"300","author":"Sen","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3389\/fimmu.2020.02045","article-title":"Cognition is associated with peripheral immune molecules in healthy older adults: a cross-sectional study","volume":"11","author":"Serre-Miranda","year":"2020","journal-title":"Front. Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J. Exp. Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1089\/neu.2013.3106","article-title":"Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury","volume":"31","author":"Shultz","year":"2014","journal-title":"J. Neurotrauma"},{"key":"B144","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mrdd.20156","article-title":"Down syndrome: cognitive phenotype","volume":"13","author":"Silverman","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/alz.12112","article-title":"Further understanding the connection between Alzheimer\u2019s disease and Down syndrome","volume":"16","author":"Snyder","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B146","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.3390\/ijms21155553","article-title":"Inhibition of colony-stimulating factor 1 receptor by PLX3397 prevents amyloid \u03b2 pathology and rescues dopaminergic signaling in aging 5xFAD mice","volume":"21","author":"Son","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B148","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00001756-199602290-00010","article-title":"Alzheimer\u2019s \u03b2-amyloid peptide is conformationally modified by apolipoprotein E in vitro","volume":"7","author":"Soto","year":"1996","journal-title":"Neuroreport"},{"key":"B149","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat. Commun."},{"key":"B150","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.gene.2012.10.051","article-title":"Expression of trisomic proteins in Down syndrome model systems","volume":"512","author":"Spellman","year":"2013","journal-title":"Gene"},{"key":"B151","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B153","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1152\/ajpregu.00421.2010","article-title":"Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic \u03b2-cells: evidence for regulation by Rac1","volume":"300","author":"Subasinghe","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"key":"B156","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","article-title":"Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline","volume":"76","author":"Taipa","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-020-00755-7","article-title":"Associations of Alzheimer\u2019s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration","volume":"13","author":"Tan","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/1389203718666171009111835","article-title":"RUNX1: a regulator of NF-kB signaling in pulmonary diseases","volume":"19","author":"Tang","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/331528a0","article-title":"Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer\u2019s disease","volume":"331","author":"Tanzi","year":"1988","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer\u2019s disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B161","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ejn.13105","article-title":"Granulocyte macrophage colony-stimulating factor treatment results in recovery of motor function after white matter damage in mice","volume":"43","author":"Theoret","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11357-011-9301-x","article-title":"The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study","volume":"34","author":"Trollor","year":"2012","journal-title":"Age"},{"key":"B163","doi-asserted-by":"publisher","first-page":"108407","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","article-title":"Down syndrome: neurobiological alterations and therapeutic targets","volume":"98","author":"Vacca","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e30525","DOI":"10.1371\/journal.pone.0030525","article-title":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease","volume":"7","author":"Westin","year":"2012","journal-title":"PLoS One"},{"key":"B168","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","article-title":"Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease","volume":"7","author":"Whelan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B169","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down\u2019s syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B170","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B173","first-page":"1030","article-title":"Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am. J. Pathol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1212\/wnl.35.7.957","article-title":"Alzheimer\u2019s disease in Down\u2019s syndrome: clinicopathologic studies","volume":"35","author":"Wisniewski","year":"1985","journal-title":"Neurology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-c","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci. Lett."},{"key":"B174","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/bbrc.1993.1423","article-title":"Apolipoprotein E: binding to soluble Alzheimer\u2019s \u03b2-amyloid","volume":"192","author":"Wisniewski","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B175","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.4049\/jimmunol.180.6.4273","article-title":"A critical role for ABCG1 in macrophage inflammation and lung homeostasis","volume":"180","author":"Wojcik","year":"2008","journal-title":"J. Immunol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10048-007-0087-z","article-title":"Association study of cholesterol-related genes in Alzheimer\u2019s disease","volume":"8","author":"Wollmer","year":"2007","journal-title":"Neurogenetics"},{"key":"B177","doi-asserted-by":"publisher","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4049\/jimmunol.168.3.1405","article-title":"Expression and regulation of aggrecanase in arthritis: the role of TGF-\u03b2","volume":"168","author":"Yamanishi","year":"2002","journal-title":"J. Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4161\/auto.7.7.15596","article-title":"Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis","volume":"7","author":"Yang","year":"2011","journal-title":"Autophagy"},{"key":"B180","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.yjmcc.2011.02.011","article-title":"The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection","volume":"50","author":"Yuen","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"84489","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B182","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","article-title":"APOE genotype alters glial activation and loss of synaptic markers in mice","volume":"60","author":"Zhu","year":"2012","journal-title":"Glia"},{"key":"B183","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2005.08.002","article-title":"Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome","volume":"390","author":"Zigman","year":"2005","journal-title":"Neurosci. Lett."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.718426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T01:21:38Z","timestamp":1631755298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.718426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":183,"alternative-id":["10.3389\/fnagi.2021.718426"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.718426","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"article-number":"718426"}}